Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark H Wilcox

Showing results (11-20 of 267) with videos related to

Pageof 27
Sort By:
Hospital Medicine (London, England : 1998)|March 29, 2005
Antibiotic prescribing as a risk factor for MRSAMark H Wilcox
Surgical Infections|March 3, 2006
Tigecycline and the need for a new broad-spectrum antibiotic classMark H Wilcox
Expert Opinion on Pharmacotherapy|October 13, 2005
Update on linezolid: the first oxazolidinone antibioticMark H Wilcox
Current Opinion in Gastroenterology|November 3, 2017
Gastrointestinal infectionsMark H Wilcox
BMJ (Clinical Research Ed.)|April 18, 2008
Screening for MRSAMark H Wilcox
The Journal of Antimicrobial Chemotherapy|May 6, 2003
Efficacy of linezolid versus comparator therapies in Gram-positive infectionsMark H Wilcox
Hospital Medicine (London, England : 1998)|March 5, 2004
Health-care-associated infection: morbidity, mortality and costsMark H Wilcox
Journal of Infection Prevention|October 10, 2017
Reply to '<i>Clostridium difficile</i> period of increased incidence in hospitals'Mark H Wilcox
The Journal of Infection|September 22, 2009
Future gazing in the management of multiply drug-resistant Gram-positive infectionMark H Wilcox
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2014
Editorial Commentary: the trials and tribulations of treating Clostridium difficile infection-one step backward, one step forward, but still progressMark H Wilcox
Pageof 27

Showing results (11-20 of 267) with videos related to

Sort By:
Pageof 27
Hospital Medicine (London, England : 1998)|March 29, 2005
Antibiotic prescribing as a risk factor for MRSAMark H Wilcox
Surgical Infections|March 3, 2006
Tigecycline and the need for a new broad-spectrum antibiotic classMark H Wilcox
Expert Opinion on Pharmacotherapy|October 13, 2005
Update on linezolid: the first oxazolidinone antibioticMark H Wilcox
Current Opinion in Gastroenterology|November 3, 2017
Gastrointestinal infectionsMark H Wilcox
BMJ (Clinical Research Ed.)|April 18, 2008
Screening for MRSAMark H Wilcox
The Journal of Antimicrobial Chemotherapy|May 6, 2003
Efficacy of linezolid versus comparator therapies in Gram-positive infectionsMark H Wilcox
Hospital Medicine (London, England : 1998)|March 5, 2004
Health-care-associated infection: morbidity, mortality and costsMark H Wilcox
Journal of Infection Prevention|October 10, 2017
Reply to '<i>Clostridium difficile</i> period of increased incidence in hospitals'Mark H Wilcox
The Journal of Infection|September 22, 2009
Future gazing in the management of multiply drug-resistant Gram-positive infectionMark H Wilcox
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2014
Editorial Commentary: the trials and tribulations of treating Clostridium difficile infection-one step backward, one step forward, but still progressMark H Wilcox
Pageof 27